SHANNON DEAN,LUISI BRAIN,KRAWIEC MARIUSZ,KULDIPKUMAR ANUJ K
申请号:
CL2013002027
公开号:
CL2013002027A1
申请日:
2013.07.12
申请国别(地区):
CL
年份:
2013
代理人:
摘要:
The present application is directed to solid forms of compounds of formula I: and pharmaceutically acceptable salts thereof, that inhibit bacterial gyrase and/or Topo IV and pharmaceutical compositions comprising said compounds and salts. These compounds and salts are useful in treating bacterial infections.FORMAS CRISTALINAS I Y II DE (R)-1-ETIL-3-[6-FLUORO-5-[2-(1-HIDROXI-1-METIL-ETIL)PIRIMIDIN-5-IL]-7(TETRAHIDROFURAN-2-IL)-1H-BENZIMIDAZOL-2-IL]UREA, INHIBIDOR DE GIRASA; COMPOSICION FARMECEUTICA; Y USO POARA TRATAR O REDUCIR UNA INFECCION BACTERIANA.